from Nichols:
http://www.unboundmedicine.com/medl...erent_than_the_first_temporal_phase_of_action
possibly the unique profile of LSD has something to do with the delayed action dopaminergic effects. LSD 90 in the abstract refers to the action of LSD at 90 minutes rather than any new flavor of LSD.
http://www.unboundmedicine.com/medl...erent_than_the_first_temporal_phase_of_action
possibly the unique profile of LSD has something to do with the delayed action dopaminergic effects. LSD 90 in the abstract refers to the action of LSD at 90 minutes rather than any new flavor of LSD.
Pharmacol Biochem Behav 2007 Jun 14.
Abstract Activation of 5-HT(2A) receptors is thought to mediate the hallucinogenic effects of LSD. Nevertheless, in a previous report we provided evidence that a delayed temporal phase of the behavioral pharmacology of LSD is mediated by D(2)-like dopamine receptor stimulation. In this study rats were trained to discriminate LSD with either a 30 min preinjection time (LSD-30, N=12) or a 90 min preinjection time (LSD-90, N=13) from saline, using a two-lever, food-reinforced operant conditioning task. We then tested a large number of agonists and antagonists belonging to distinct pharmacological classes in these animals. As anticipated, classical hallucinogens such as psilocin and mescaline substituted only in LSD-30 rats, and not in LSD-90 rats. The dopamine receptor agonists ABT-724, aripiprazole, dihydrexidine, WAY 100635, and SKF 38393, fully or partially mimicked LSD-90, but not LSD-30. The results reported here support and extend our previous conclusion that the delayed temporal effects of LSD are mediated by activation of a dopaminergic system.
